Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ergogenic aids: an update on ephedra.

Brian D Keisler1, Robert G Hosey

  • 1University of Kentucky, K308 Kentucky Clinic, 740 S. Limestone, Lexington, KY 40536, USA.

Current Sports Medicine Reports
|July 12, 2005
PubMed
Summary

Ephedra supplements, once popular for weight loss and athletic performance, were banned by the FDA in 2004 due to serious cardiovascular and central nervous system adverse effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Could Workplace-Based Assessments Improve Faculty Teaching Confidence and Competence?

PRiMER (Leawood, Kan.)·2024
Same author

Effect of Pitching Restrictions and Mound Distance on Youth Baseball Pitch Counts.

Orthopaedic journal of sports medicine·2022
Same author

A Case Series and Literature Review: Isolated Traumatic First Rib Fracture in Athletes.

Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine·2018
Same author

The evolution of an integrated ultrasound curriculum (iUSC) for medical students: 9-year experience.

Critical ultrasound journal·2015
Same author

Trends in concussion return-to-play timelines among high school athletes from 2007 through 2009.

Journal of athletic training·2013
Same author

Hip strengthening prior to functional exercises reduces pain sooner than quadriceps strengthening in females with patellofemoral pain syndrome: a randomized clinical trial.

The Journal of orthopaedic and sports physical therapy·2011

Area of Science:

  • Pharmacology
  • Herbal Medicine
  • Public Health

Background:

  • Ephedra, utilized in traditional Chinese medicine for millennia, gained popularity in Western medicine in the 20th century.
  • Its amphetamine-like properties led to widespread use in weight loss and athletic performance supplements, despite limited scientific evidence.
  • The Dietary Supplement Health and Education Act of 1994 reduced FDA oversight, increasing the availability of ephedra products.

Purpose of the Study:

  • To review the historical use and adverse effects of ephedra-containing supplements.
  • To examine the regulatory history and eventual ban of ephedra products by the FDA.
  • To highlight the link between ephedra's sympathomimetic activity and associated health risks.

Main Methods:

  • Literature review of historical medical texts and scientific publications.
  • Analysis of adverse event reports associated with ephedra supplementation.
  • Examination of regulatory actions taken by the US Food and Drug Administration (FDA).

Main Results:

  • Ephedra's sympathomimetic activity is linked to significant adverse effects, including cardiovascular and central nervous system diseases.
  • Increased availability post-1994 led to a rise in reported adverse events.
  • Mounting evidence of harm prompted the FDA to ban ephedra supplements in April 2004.

Conclusions:

  • Ephedra-containing supplements pose serious health risks due to their sympathomimetic properties.
  • Regulatory oversight is crucial for ensuring the safety of dietary supplements.
  • The FDA's ban underscores the importance of evidence-based safety assessments for herbal products.

Related Experiment Videos